BACKGROUND: The health benefits of diet and exercise interventions for cancer survivors are well documented. However, little is known regarding demographic and medical predictors of survivors' willingness to participate in diet and exercise intervention trials, study enrollment, intervention adherence, and study completion. To assist in interpreting the generalizability of trial findings and to improve the design of future trials, this study examined predictors of these process measures. METHODS: An integrative data analysis was performed on data from 3 of the largest home-based diet and exercise intervention trials for cancer survivors (n = 23,841). Demographic and medical factors (ie, sex, race, age, time since diagnosis, and cancer type) were examined as predictors of willingness to participate, study enrollment, intervention adherence, and study completion in the pooled sample. A 99% confidence interval was used to determine statistical significance. RESULTS: Across trials, 11.1% of contacted survivors were willing to participate, and 5.7% were eligible and enrolled. Among enrollees, 53.4% demonstrated ≥75% adherence to the intervention, and 91.1% completed the study. Race (Caucasian vs others), age, time since diagnosis, and cancer type predicted survivors' willingness to participate (P < .01). All examined predictors were associated with the likelihood of study enrollment (P < .01). No significant predictors of intervention adherence or study completion were found among study enrollees (P ≥ .01). CONCLUSIONS: Cancer survivors' demographic and medical characteristics predicted their interest and participation in diet and exercise intervention trials. These findings have implications for the generalizability of results and can help to guide procedures used in future trials to enhance patient representation.
BACKGROUND: The health benefits of diet and exercise interventions for cancer survivors are well documented. However, little is known regarding demographic and medical predictors of survivors' willingness to participate in diet and exercise intervention trials, study enrollment, intervention adherence, and study completion. To assist in interpreting the generalizability of trial findings and to improve the design of future trials, this study examined predictors of these process measures. METHODS: An integrative data analysis was performed on data from 3 of the largest home-based diet and exercise intervention trials for cancer survivors (n = 23,841). Demographic and medical factors (ie, sex, race, age, time since diagnosis, and cancer type) were examined as predictors of willingness to participate, study enrollment, intervention adherence, and study completion in the pooled sample. A 99% confidence interval was used to determine statistical significance. RESULTS: Across trials, 11.1% of contacted survivors were willing to participate, and 5.7% were eligible and enrolled. Among enrollees, 53.4% demonstrated ≥75% adherence to the intervention, and 91.1% completed the study. Race (Caucasian vs others), age, time since diagnosis, and cancer type predicted survivors' willingness to participate (P < .01). All examined predictors were associated with the likelihood of study enrollment (P < .01). No significant predictors of intervention adherence or study completion were found among study enrollees (P ≥ .01). CONCLUSIONS:Cancer survivors' demographic and medical characteristics predicted their interest and participation in diet and exercise intervention trials. These findings have implications for the generalizability of results and can help to guide procedures used in future trials to enhance patient representation.
Authors: Kerry S Courneya; Kristina H Karvinen; Margaret L McNeely; Kristin L Campbell; Sony Brar; Christy G Woolcott; Anne McTiernan; Rachel Ballard-Barbash; Christine M Friedenreich Journal: J Phys Act Health Date: 2011-09-13
Authors: Jean G Ford; Mollie W Howerton; Gabriel Y Lai; Tiffany L Gary; Shari Bolen; M Chris Gibbons; Jon Tilburt; Charles Baffi; Teerath Peter Tanpitukpongse; Renee F Wilson; Neil R Powe; Eric B Bass Journal: Cancer Date: 2008-01-15 Impact factor: 6.860
Authors: Marjorie L McCullough; Alpa V Patel; Lawrence H Kushi; Roshni Patel; Walter C Willett; Colleen Doyle; Michael J Thun; Susan M Gapstur Journal: Cancer Epidemiol Biomarkers Prev Date: 2011-04-05 Impact factor: 4.254
Authors: Wendy Demark-Wahnefried; Elizabeth C Clipp; Miriam C Morey; Carl F Pieper; Richard Sloane; Denise Clutter Snyder; Harvey J Cohen Journal: J Clin Oncol Date: 2006-07-20 Impact factor: 44.544
Authors: Vivian E von Gruenigen; Kerry S Courneya; Heidi E Gibbons; Mary Beth Kavanagh; Steven E Waggoner; Edith Lerner Journal: Gynecol Oncol Date: 2008-02-19 Impact factor: 5.482
Authors: Maria Pisu; Wendy Demark-Wahnefried; Kelly M Kenzik; Robert A Oster; Chee Paul Lin; Sharon Manne; Ronald Alvarez; Michelle Y Martin Journal: J Cancer Surviv Date: 2017-01-09 Impact factor: 4.442
Authors: A Rundle; S Iles; K Matheson; L E Cahill; C C Forbes; N Saint-Jacques; R Urquhart; T Younis Journal: Curr Oncol Date: 2020-06-01 Impact factor: 3.677
Authors: Andrea M Hussong; Nisha C Gottfredson; Dan J Bauer; Patrick J Curran; Maleeha Haroon; Redonna Chandler; Shoshana Y Kahana; Joseph A C Delaney; Frederick L Altice; Curt G Beckwith; Daniel J Feaster; Patrick M Flynn; Michael S Gordon; Kevin Knight; Irene Kuo; Lawrence J Ouellet; Vu M Quan; David W Seal; Sandra A Springer Journal: Drug Alcohol Depend Date: 2018-10-23 Impact factor: 4.492
Authors: Catherine E Mosher; Joseph G Winger; Barbara A Given; Safi Shahda; Paul R Helft Journal: Support Care Cancer Date: 2017-04-22 Impact factor: 3.603
Authors: Daniela L Stan; Katrina A Croghan; Ivana T Croghan; Sarah M Jenkins; Stephanie J Sutherland; Andrea L Cheville; Sandhya Pruthi Journal: Support Care Cancer Date: 2016-04-29 Impact factor: 3.603